Insufficient scRNA-seq data for expression of CCKAR at single-cell level.
Insufficient scRNA-seq data for expression of CCKAR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 93% | 710.30 | 333 / 359 | 12% | 0.64 | 35 / 286 |
| esophagus | 44% | 29.63 | 640 / 1445 | 4% | 0.38 | 7 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 40% | 1.27 | 18 / 45 |
| breast | 31% | 9.71 | 141 / 459 | 4% | 0.07 | 49 / 1118 |
| brain | 30% | 10.33 | 790 / 2642 | 5% | 0.16 | 34 / 705 |
| intestine | 28% | 14.45 | 273 / 966 | 4% | 0.24 | 22 / 527 |
| kidney | 26% | 4.02 | 23 / 89 | 5% | 0.77 | 48 / 901 |
| pancreas | 13% | 2.88 | 41 / 328 | 6% | 0.66 | 10 / 178 |
| uterus | 9% | 2.09 | 16 / 170 | 5% | 0.75 | 21 / 459 |
| lung | 2% | 0.46 | 13 / 578 | 5% | 0.36 | 60 / 1155 |
| heart | 7% | 1.15 | 64 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 2% | 0.26 | 5 / 258 | 3% | 0.16 | 7 / 230 |
| prostate | 1% | 0.09 | 2 / 245 | 3% | 0.06 | 13 / 502 |
| thymus | 0% | 0 | 0 / 653 | 3% | 0.08 | 16 / 605 |
| blood vessel | 2% | 0.35 | 28 / 1335 | 0% | 0 | 0 / 0 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.04 | 7 / 504 |
| skin | 0% | 0.06 | 7 / 1809 | 1% | 0.16 | 4 / 472 |
| ovary | 0% | 0 | 0 / 180 | 1% | 0.24 | 4 / 430 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 2 / 406 |
| adipose | 0% | 0.45 | 2 / 1204 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007409 | Biological process | axonogenesis |
| GO_0046883 | Biological process | regulation of hormone secretion |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0032870 | Biological process | cellular response to hormone stimulus |
| GO_0001764 | Biological process | neuron migration |
| GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO_0038188 | Biological process | cholecystokinin signaling pathway |
| GO_0030900 | Biological process | forebrain development |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0042277 | Molecular function | peptide binding |
| GO_0004951 | Molecular function | cholecystokinin receptor activity |
| GO_0017046 | Molecular function | peptide hormone binding |
| Gene name | CCKAR |
| Protein name | Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R) |
| Synonyms | CCKRA |
| Description | FUNCTION: Receptor for cholecystokinin. Mediates pancreatic growth and enzyme secretion, smooth muscle contraction of the gall bladder and stomach. Has a 1000-fold higher affinity for CCK rather than for gastrin. It modulates feeding and dopamine-induced behavior in the central and peripheral nervous system. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. |
| Accessions | ENST00000295589.4 P32238 |